The aim of the New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) study is to monitor trends in alcohol and other drug use among police detainees in New Zealand, and to document the harms associated with this substance use. NZ-ADUM tracks key indicators of illegal drug markets, such as availability and price, and identifies emergent new drug types, such as synthetic cannabinoids. NZ-ADUM also assesses the level of demand for drug treatment services among police detainees, and the barriers they experience in accessing these services. The 2016 NZ-ADUM interviewed 800 police detainees at four central city police watch houses (i.e. Whangarei, Auckland Central, Wellington Central and Christchurch Central) from June to October 2016. Urine samples were collected from 202 of the interviewed detainees to confirm the drug types used. This report presents the findings from the 2016 NZ-ADUM and compares them with the previous five years of the study.
The New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) study monitors levels of alcohol and other drug use, and related criminal offending, among police detainees in Whangarei, Auckland, Wellington and Christchurch central city police stations (see Wilkins et al., 2010b). NZ-ADUM tracks key drugs of concern, including methamphetamine, cannabis, opioids, pharmaceutical medicines and new psychoactive substances (NPS) (so called ‘legal highs’), as well as the emergence of entirely new drugs. NZ-ADUM also documents levels of alcohol and drug related harm, demand for drug treatment services, and changes in key illegal drug market indicators, such as availability and price.
This report presents the findings from the 2014 NZ-ADUM and compares them with the findings from the previous four years of the study.